Trials / Completed
CompletedNCT06128200
NEUROMARK Randomized Controlled Trial
Randomized Controlled Trial Comparing NEUROMARK System to Sham Control in Patients With Chronic Rhinitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- Neurent Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The NEUROMARK RCT Study is a prospective, multicenter, randomized, sham-controlled, single-blinded, superiority trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NEUROMARK System | The NEUROMARK System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis. |
| DEVICE | Sham NEUROMARK System | Sham ablation procedure using the NEUROMARK System |
Timeline
- Start date
- 2023-10-10
- Primary completion
- 2025-11-26
- Completion
- 2025-11-26
- First posted
- 2023-11-13
- Last updated
- 2026-03-19
Locations
16 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06128200. Inclusion in this directory is not an endorsement.